← Back to Clinical Trials
Recruiting NCT06963658

NCT06963658 Acute Effect of Isometric Excercise on Pain Sensitivity in Adults With Chronic Low Back Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06963658
Status Recruiting
Phase
Sponsor Taif University
Condition Chronic Low Back Pain (CLBP)
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2025-08-01
Primary Completion 2025-10-01

Trial Parameters

Condition Chronic Low Back Pain (CLBP)
Sponsor Taif University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 90
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-08-01
Completion 2025-10-01
Interventions
Multiple repetition isometric wall squatMultiple Isometric wall squat exercise + Double Leg Lower with Isometric HoldControl quiet seated rest

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Randomized control trial to examine the immediate effect of isometric exercise on pressure pain threshold (PPT) in adults with chronic low back pain. The secondary aim of this study was to investigate the acute effects of isometric exercise on clinical pain intensity.

Eligibility Criteria

Inclusion Criteria : 1. participants aged ≥18 years or older 2. participant diagnosed with non-specific chronic lower back pain (\> 12 weeks) 3. Able to perform physical therapy excercise . Exclusion criteria : The study will exclude 1- pregnant women 2- lactating women for one or less than one year post-natal. 3- any certain medical conditions that could interfere with physical activity, including: * uncontrolled diabetes * cardiovascular problem * orthopedic impairments * balance problems. 4-serious spinal pathologies : * infection * fractures * tumors * inflammatory diseases like ankylosing spondylitis 5- neurological compromise, * spinal nerve compromise * cauda equina syndrome

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology